Navigation Links
XTL in Medical News

Notification of Annual General Meeting and Extraordinary General Meeting

...ty's site: http://www.magna.isa.gov.il . ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...he treatment of diabetic neuropathic pain and HCV. xtl is developing Bicifadine, a serotonin and norepine...

XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007

...ital well into the first quarter of 2009." ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...he treatment of diabetic neuropathic pain and HCV. xtl is developing Bicifadine, a serotonin and norepine...

XTL Announces Delisting From the Official List of the United Kingdom Listing Authority

...SDAQ, or trade their ordinary shares on the TASE. xtl Biopharmaceuticals Ltd. has further announced that...1-212-815-3004, jpaltrowitz@bankofny.com About xtl Biopharmaceuticals Ltd. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...
XTL in Medical Technology

XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma

...EHOVOT, Israel, March 18 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XT...ent for a severe and incurable blood cancer. We at xtl are thrilled at this opportunity and expect to emb...ce with the terms of the asset purchase agreement, xtl will issue Bio-GAL Ltd. ordinary shares representi...

XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain

...rly await the outcome of this study in Q4 2008." xtl in-licensed the world-wide rights to Bicifadine fr..., Inc. (NASDAQ OTC: DOVP) in January 2007. ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...

XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis

...gnificant side affects associated with it. ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...ics for the treatment of neuropathic pain and HCV. xtl is developing Bicifadine, a serotonin and norepine...

XTL Provides Update on Phase I Clinical Trial of XTL-2125

... New York, June 06, 2007 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. announced today that it ha...rved in the placebo group. Based on these results, xtl has decided to suspend further development of XTL-...f this Phase I trial concludes our research on the xtl legacy compounds that we inherited. Through an agg...
XTL in Biological Technology

Extraordinary General Meetings Statement -- XTL Also Announces Board and Management Changes

REHOVOT, Israel, March 18 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announces the results of its Extraordinary General Meetings ("EGMs") held earlier today. All of the resolutions at the EGMs were passed. The current board of directors consists of Mark...

Corrected: XTL Biopharmaceuticals to Convene Extraordinary Shareholders' Meetings after Receipt of Shareholder Letter

VALLEY COTTAGE, N.Y., Feb. 5 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB , TASE: XTL) today provided notification that on February 3, 2009 the Company received a letter from a shareholder who owns more than 5% of the Company's outstanding ordinary shares requesting th...

Extraordinary General Meetings Statement - XTL Notifies NASDAQ of Compliance with Marketplace Rule 4350(d)(2)

VALLEY COTTAGE, N.Y., Oct. 10 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announces the results of its Extraordinary General Meetings ("EGMs") held earlier today. The outcome of the EGMs was as follows: all of the resolutions passed and Jennifer L. Good ...

XTL to Appeal NASDAQ Staff Determination; XTL May Transfer its ADR Listing to the NASDAQ Capital Market

VALLEY COTTAGE, New York, September 26 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: XTL) today announced that on September 24, 2007, the Company received a NASDAQ Staff Determination indicating that the Company fails to comply with the minimum $10 mill...

Reminder: XTL to Hold a Conference Call Today at 8:30 am EDT to Discuss the Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain

VALLEY COTTAGE, New York, September 11 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: XTL) will hold a conference call today, September 11, 2007, at 8:30 a.m. EDT to discuss the Phase IIb clinical trial of Bicifadine for the treatment of diabetic neuropa...

XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market

NEW YORK, August 28 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: XTL), a biopharmaceutical company engaged in the acquisition, development and commercialization of therapeutics for the treatment of unmet medical needs, particularly neuropathic pain and...

Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer

...f all of our stakeholders." Ron Bentsur has more than a decade of experience in the biotech industry. Most recently, Mr. Bentsur served as CEO of xtl Biopharmaceuticals, a position he held from January 2006 until April 2009. Prior to his tenure at XTL, Mr. Bentsur was with the Company from 2000-200...

XTL Biopharmaceuticals Ltd. Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel

...EHOVOT, Israel, April 16 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. (Nasdaq: XTLB , TASE: XT... proceed with the delisting process. ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...

XTL Biopharmaceuticals Ltd. Extraordinary General Meetings Postponed Until March 18, 2009

... VALLEY COTTAGE, N.Y., March 11 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announced today that its Extraordinary General Meetings ("EGMs") were postponed for one week in a...

XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors

...Mr. Shweiger received an LL.B, magna cum laude, from the College of Management and an MBA in finance and auditing from Tel - Aviv University . xtl also announced that its appeal hearing date for its Nasdaq listing has been changed to March 19, 2009 from March 12, 2009. Cautionary Statemen...
Other Tags
(Date:3/27/2015)... Airy Jeanine is a rising star. ... video for her debut song “Mama’s Girl”, launched on ... abstract styling effects, the thematic video for the rhythmic ... and assorted outlets. It will be integral in establishing, ... full-scale marketing strategy. The video promotion campaign spearheaded by ...
(Date:3/27/2015)... 27, 2015 “ VXi BlueParott Reveal ... monthly Tech Report, which features the latest and coolest ... expert and special reporter for NewsWatch, conducted the review ... noise-cancelling headset, eliminating 90% of ambient noise. , Today, ... and emails are important to any professional, voice calls ...
(Date:3/27/2015)... March 27, 2015 The ... Quaker-based, philanthropic, grant-making foundation committed to raising its ... healthcare is delivered. , The Scattergood Foundation and ... Behavioral Health Policy and Practice through the Annual ... Program App is designed to guide the ...
(Date:3/26/2015)... Dr. Rod J. Rohrich, who served as ... and has trained over 6500 surgeons through these meetings ... medicine (EBM), that is, the optimization of decision making ... often hear from rhinoplasty surgeons who describe ... not trying to stifle these discussions, we do want ...
(Date:3/26/2015)... The American College of Traditional Chinese Medicine ... of the DAOM Program as well as Marketing Basics for ... be hosted by Dr. Carla Wilson, who will give an ... how to prepare for the spring quarter. The webinar will ... April 1 and April 3. Attendees can log in from ...
Breaking Medicine News(10 mins):Health News:Airy Jeanine Releases ‘’Mama’s Girl” Official Music Video 2Health News:A Device to Tune out Background Noise was Recently Featured on NewsWatch Television 2Health News:SoundsLikeIBS Nominated For 3rd Annual Scattergood Innovation Award 2Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:ACTCM Announces Upcoming Webinars 2
(Date:3/3/2015)... FOREST, Calif. , March 3, 2015 ... the leading provider of advanced cryogenic logistics ... markets including immunotherapies, stem cells, cell lines, ... and reproductive medicine, today announced the expansion ... Cancer Research Centers, ("Fred Hutch") Clinical ...
(Date:3/2/2015)...  Businesses have a new option for premier ... Enterprises has announced the launch of a brand ... businesses to protect their customers, personal data, as ... Beconux is a biometric transaction processing system recently ... an ATM machine, the new system fuses multiple ...
(Date:2/25/2015)... Feb. 25, 2015  ABC Financial Services (ABC), ... the Health and Fitness Industry, today announced enhancements ... MYiCLUBonline.  The latest upgrade includes advances to the ... cardless check-in via Identity One fingerprint biometrics. The ... through interactive displays at the International Health, Racquet ...
Breaking Biology News(10 mins):Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3Personal Data Protection Company Launches New Product 2ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3
Other Contents